Indivior Pharmaceuticals (INDV) Net Income towards Common Stockholders (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted Net Income towards Common Stockholders of $122 million for Q2 2026, up 577.8% from $18 million a year earlier and up 37.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Indivior Pharmaceuticals was $355 million, up 228.7% year-over-year; for FY2025, it came in at $210 million.
- Annual Net Income towards Common Stockholders shows a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
- In prior years, Indivior Pharmaceuticals' Net Income towards Common Stockholders was $7 million in FY2024, -$126 million in FY2023, -$42 million in FY2022 and $205 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Net Income towards Common Stockholders in data going back to Q1 2024.
- On a year-over-year basis, Net Income towards Common Stockholders has increased in each of the last four quarters, with growth averaging 224.2% over the last five quarters.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $89 million (Q1 2026), $102 million (Q4 2025) and $42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 47.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -97.00 Mn |
| Mar 31, 2024 | 61.00 Mn |
API Access
Indivior Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();